Ranbaxy Enters Yemen

Indian generics multinational Ranbaxy Laboratories has entered Yemen's pharmaceutical market through a tie up with Yemen's National Trading Company (Natco). The deal will see Natco market a number of Ranbaxy's drugs in Yemen. Ranbaxy is currently seeking approval for several drugs, thought to include anti-infective, gastro-intestinal and anti-allergy products, with Yemen's Supreme Board for Drugs & Medical

To read the full article, please choose one of the following options: